A Retrospective Chart Review to Update Previously Collected Data and to Obtain Missing Data from D-1633, a Terminated Phase 2 trial of Gemzar/Taxol in Patients with Previously Treated Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Phase of Trial: Phase II
Latest Information Update: 15 May 2013
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 12 Nov 2012 New trial record